Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
Combating Diseases with Limited Investment Incentives: Q&A with Dr. Claire Wagner
Pharmaceutical Executive October 4, 2024
Dr. Wagner discusses her work with the Bill and Melinda Gates Medical Research Institute.
An unfortunate reality of the pharmaceutical industry is that profit is often more of a motivator for drug development than helping patients. As head of corporate strategy and market access at the Bill Melinda Gates Medical Research Institute, Dr. Claire Wagner works to get medications produced or developed that are sorely needed but may not fit into the typical profit-structure of a commercial pharmaceutical company.
Pharmaceutical Executive: What are the largest global health concerns for which investment incentives are limited?
Dr. Claire Wagner: The COVID-19 pandemic showed some critical vulnerabilities in health systems across high income countries with strong economies, regardless of income levels. At the Gates...
Today's Sponsors
Today's Sponsor